Showing results (101-110 of 152) with videos related to

Sort By:
Pageof 16
Plos One|December 21, 2010
Comparative analysis of the lambda-interferons IL-28A and IL-29 regarding their transcriptome and their antiviral properties against hepatitis C virusJulia Diegelmann, Florian Beigel, Kathrin Zitzmann, et al.
Regulatory Peptides|March 31, 2009
Effects of the cathelicidin LL-37 on intestinal epithelial barrier integrityJan-Michel Otte, Anna-Elisabeth Zdebik, Stephan Brand, et al.
International Orthopaedics|September 10, 2013
Repair of segmental long-bone defects by stem cell concentrate augmented scaffolds: a clinical and positron emission tomography--computed tomography analysisMaximilian Petri, Ali Namazian, Florian Wilke, et al.
Journal of Crohn'S & Colitis|June 24, 2014
Colesevelam for the treatment of bile acid malabsorption-associated diarrhea in patients with Crohn's disease: a randomized, double-blind, placebo-controlled studyFlorian Beigel, Niels Teich, Stefanie Howaldt, et al.
Plos One|November 14, 2013
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2Julia Diegelmann, Darina Czamara, Emmanuelle Le Bras, et al.
Neuroendocrinology|February 21, 2007
The novel mTOR inhibitor RAD001 (everolimus) induces antiproliferative effects in human pancreatic neuroendocrine tumor cellsKathrin Zitzmann, Enrico N De Toni, Stephan Brand, et al.
Inflammatory Bowel Diseases|August 12, 2015
Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-α and Modulated by IL23R Genotype StatusJohannes Stallhofer, Matthias Friedrich, Astrid Konrad-Zerna, et al.
Biochemical and Biophysical Research Communications|April 27, 2005
SOCS-1 inhibits expression of the antiviral proteins 2',5'-OAS and MxA induced by the novel interferon-lambdas IL-28A and IL-29Stephan Brand, Kathrin Zitzmann, Julia Dambacher, et al.
Inflammatory Bowel Diseases|September 20, 2011
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgeryMichael S Kasparek, Andreas Bruckmeier, Florian Beigel, et al.
Clinical and Translational Gastroenterology|January 14, 2022
Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin ExpressionJohannes Stallhofer, Lisa Veith, Julia Diegelmann, et al.
Pageof 16